These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18703486)

  • 1. Glucagon-like peptide 1-receptor scans to localize occult insulinomas.
    Wild D; Mäcke H; Christ E; Gloor B; Reubi JC
    N Engl J Med; 2008 Aug; 359(7):766-8. PubMed ID: 18703486
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucagon-like peptide-1 receptor imaging for localization of insulinomas.
    Christ E; Wild D; Forrer F; Brändle M; Sahli R; Clerici T; Gloor B; Martius F; Maecke H; Reubi JC
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4398-405. PubMed ID: 19820010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study.
    Christ E; Wild D; Ederer S; Béhé M; Nicolas G; Caplin ME; Brändle M; Clerici T; Fischli S; Stettler C; Ell PJ; Seufert J; Gloor B; Perren A; Reubi JC; Forrer F
    Lancet Diabetes Endocrinol; 2013 Oct; 1(2):115-22. PubMed ID: 24622317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. For insulinomas, no place to hide.
    Nauck MA; Meier JJ
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4125-6. PubMed ID: 19890029
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma.
    Wicki A; Wild D; Storch D; Seemayer C; Gotthardt M; Behe M; Kneifel S; Mihatsch MJ; Reubi JC; Mäcke HR; Christofori G
    Clin Cancer Res; 2007 Jun; 13(12):3696-705. PubMed ID: 17575235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC- 99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma.
    Sowa-Staszczak A; Pach D; Mikołajczak R; Mäcke H; Jabrocka-Hybel A; Stefańska A; Tomaszuk M; Janota B; Gilis-Januszewska A; Małecki M; Kamiński G; Kowalska A; Kulig J; Matyja A; Osuch C; Hubalewska-Dydejczyk A
    Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):524-31. PubMed ID: 23224740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 68Ga-NOTA-exendin-4 PET/CT in detection of occult insulinoma and evaluation of physiological uptake.
    Luo Y; Yu M; Pan Q; Wu W; Zhang T; Kiesewetter DO; Zhu Z; Li F; Chen X; Zhao Y
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):531-2. PubMed ID: 25398421
    [No Abstract]   [Full Text] [Related]  

  • 8. Preclinical studies of SPECT and PET tracers for NET.
    Brom M; Boerman O; Gotthardt M; Oyen WJ
    PET Clin; 2014 Jan; 9(1):63-9. PubMed ID: 25029935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLP-1-receptor scanning for imaging of human beta cells transplanted in muscle.
    Pattou F; Kerr-Conte J; Wild D
    N Engl J Med; 2010 Sep; 363(13):1289-90. PubMed ID: 20860517
    [No Abstract]   [Full Text] [Related]  

  • 10. [An occult pancreatic insulinoma: radio-guided surgery with 111-In-octreotide. A case report and review of the literature on pre- and intraoperative diagnosis].
    Ressetta G; Geatti O; Pozzetto B; Sustersich M; Povolato M; Ferretti G; Leggeri A
    Ann Ital Chir; 2000; 71(1):107-12; discussion 113. PubMed ID: 10829532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.
    Wild D; Béhé M; Wicki A; Storch D; Waser B; Gotthardt M; Keil B; Christofori G; Reubi JC; Mäcke HR
    J Nucl Med; 2006 Dec; 47(12):2025-33. PubMed ID: 17138746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The imaging of insulinomas using a radionuclide-labelled molecule of the GLP-1 analogue liraglutide: a new application of liraglutide.
    Lv J; Pan Y; Li X; Cheng D; Liu S; Shi H; Zhang Y
    PLoS One; 2014; 9(5):e96833. PubMed ID: 24805918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localisation of occult extra-pancreatic insulinoma using glucagon-like peptide-1 receptor molecular imaging.
    Mossman AK; Pattison DA; Hicks RJ; Hamblin PS; Yates CJ
    Intern Med J; 2018 Jan; 48(1):97-98. PubMed ID: 29314520
    [No Abstract]   [Full Text] [Related]  

  • 14. Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas.
    Wild D; Christ E; Caplin ME; Kurzawinski TR; Forrer F; Brändle M; Seufert J; Weber WA; Bomanji J; Perren A; Ell PJ; Reubi JC
    J Nucl Med; 2011 Jul; 52(7):1073-8. PubMed ID: 21680696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPECT imaging with 111In-octreotide for the localization of pancreatic insulinoma.
    Signore A; Procaccini E; Chianelli M; Salerno G; Iozzo P; Annovazzi A; Leonetti F; Tamburrano G; Ronga G
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):111-2. PubMed ID: 9002765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nuclear option for insulinomas.
    Grossman A
    Lancet Diabetes Endocrinol; 2013 Oct; 1(2):82-4. PubMed ID: 24622306
    [No Abstract]   [Full Text] [Related]  

  • 17. Pitfalls in the Detection of Insulinomas With Glucagon-Like Peptide-1 Receptor Imaging.
    Antwi K; Hepprich M; Müller NA; Reubi JC; Fani M; Rottenburger C; Nicolas G; Kaul F; Christ ER; Wild D
    Clin Nucl Med; 2020 Sep; 45(9):e386-e392. PubMed ID: 32558709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 111In-pentetreotide scintigraphy in the detection of insulinomas: importance of SPECT imaging.
    Schillaci O; Massa R; Scopinaro F
    J Nucl Med; 2000 Mar; 41(3):459-62. PubMed ID: 10716319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results.
    Gotthardt M; Fischer M; Naeher I; Holz JB; Jungclas H; Fritsch HW; Béhé M; Göke B; Joseph K; Behr TM
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):597-606. PubMed ID: 11976797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult functioning insulinomas: which localizing studies are indicated?
    van Heerden JA; Grant CS; Czako PF; Service FJ; Charboneau JW
    Surgery; 1992 Dec; 112(6):1010-4; discussion 1014-5. PubMed ID: 1455304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.